Boston Scientific Corporation (BSX) vs Stryker Corporation (SYK)

Boston Scientific Corporation and Stryker Corporation are both Medical Devices companies. Stryker Corporation is the larger, with a market value of $112.5B against $64.0B — 1.8× the size. Boston Scientific Corporation trades at the lower P/E: 17.9× against 30.3×. Boston Scientific Corporation grew revenue faster over the last twelve months: 13.5% against 8.48%. Boston Scientific Corporation has the higher net margin (17.5% vs 14.4%) and the lower return on invested capital (6.96% vs 9.76%). Across the 22 metrics below, Boston Scientific Corporation leads on 16 and Stryker Corporation on 6.

Valuation

Metric BSX SYK Medical Devices median
P/E 17.90 30.28 23.22
P/S 3.11 4.37 2.34
P/B 2.59 4.71 2.33
Price to free cash flow 18.00 24.03 23.72
EV/EBITDA 13.91 18.43 11.54
EV/Sales 3.68 4.82 2.24
Earnings yield 5.59% 3.30% (10.09%)
Free cash flow yield 5.55% 4.16% (8.47%)

Profitability

Metric BSX SYK Medical Devices median
Gross margin 69.92% 64.98% 56.01%
Operating margin 19.76% 21.42% (15.03%)
Net margin 17.50% 14.43% (20.40%)
Free cash flow margin 17.27% 18.20% (7.24%)
Return on equity 15.37% 16.51% (15.32%)
Return on assets 8.47% 7.91% (19.72%)
Return on invested capital 6.96% 9.76% (10.33%)

Growth

Metric BSX SYK Medical Devices median
Revenue growth (TTM) 13.52% 8.48% 8.80%
EPS growth (last fiscal year) 55.20% 8.25% 29.03%
Revenue growth, 5-year CAGR 15.16% 11.84% 15.47%
Net income growth, 5-year CAGR 0.00% 15.21% 0.00%

Health

Metric BSX SYK Medical Devices median
Debt to equity 0.50 0.62 0.07
Current ratio 1.24 2.16 2.50
Net debt to EBITDA 1.88 1.93 0.49

Dividend

Metric BSX SYK Medical Devices median
Dividend yield — 1.19% 1.16%
Payout ratio — 0.36 0.36

Size

Metric BSX SYK Medical Devices median
Market cap 63.97b 112.48b 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack